Search Results
Search results for "The Franklin Institute"
Results found for "The Franklin Institute"
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes
- Chris Langmead | Dr. GPCR Ecosystem
Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
Prasenjit Saha I conducted my doctoral research at the Indian Institute of Science, Bangalore, India,
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
After obtaining a Postdoctoral Fellowship from the Canadian Institutes of Health Research in 2012, Bianca
- Dr. Randy Hall | Dr. GPCR Ecosystem
After obtaining his Ph.D. in 1994, Randy moved to the Vollum Institute in Portland, Oregon, to do a post-doctoral
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
allosteric modulation of dopamine receptors in Philip Strange's UK lab and a postdoc at the National Institutes pharmacology Allosteric modulation and the mathematical foundations of receptor theory Biased agonism and constitutive He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
Laura Bohn at Scripps Research Institute. A trained pharmacologist's first instinct is that the side effect burden would be crushing. Laura Bohn’s lab at Scripps Research Institute in Florida.
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
University of Copenhagen's Department of Drug Design and Pharmacology, with a part-time affiliation at the Institute Alexander is currently a postdoc as a member of the personalized medicine cluster in Copenhagen and at the Institute
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
receptor signaling, cardiovascular physiology, mechanobiology - that exists in internal reports and institutional Arey calls this one of the most important and least instinctive skills in pharmaceutical research - and progression - each transition resets the publication clock and delays the depth of specialization that institutional For scientists trained to distrust that instinct, it is a useful challenge.
- Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem
Eleonora Comeo, PhD candidate at the University of Nottingham and the Monash Institute of Pharmaceutical GUEST Eleonora Comeo is a PhD candidate jointly enrolled at the University of Nottingham and the Monash Institute
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
He later served as Professor of Cellular Metabolism and Institute Deputy Director at the University of
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Undergraduate Research Program and is working to build relationships with key stakeholders through institutional
- The Scientist's Compass: From Academia to Entrepreneurship with Dr. Dmitry Veprintsev | Dr. GPCR Ecosystem
In 2010 he became a group leader at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
shared scientific workspace where researchers could surface big unsolved problems, correspond across institutions He completed two postdocs in the UK at the EMBL-European Bioinformatics Institute and GlaxoSmithKline
- Revvity | Dr. GPCR Ecosystem
Suitable for basal/constitutive and agonist-induced GPCR internalization Compatible with TRF plate readers She has been leading collaborative projects with public research institutes and pharmaceutical companies , most notably the joint Revvity/Institute of Functional Genomics team, EIDOS.
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
ABOUT THE GUEST Michel Bouvier is CEO of the Institut de Recherches Cliniques de Montreal (IRCM) and Bouvier presented the concept of inverse agonism - compounds that inhibit the spontaneous activity of a constitutively Michel Bouvier Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Institute
- Elva Zhao: G Protein Regulation and Biased Signaling at the GLP-1 Receptor | Dr. GPCR Ecosystem
About the Guest Elva Zhao is a Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical Sciences
- Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem
Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism
- Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem
at Columbia University, where she is part of the Department of Biological Sciences and the Zuckerman Institute
- University Pricing | Dr. GPCR Ecosystem
Find the right plan for your team — from small groups to institution-wide access.
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
After completing his Ph.D., he pursued research in genetics of metabolic regulation at the Institute
- Jane Lamerdin and Gaurav Agrawal: Building GPCR Assays That Reflect Real Biology | Dr. GPCR Ecosystem
Gaurav Agrawal earned his PhD in cell and molecular biology from the Indian Institute of Science, studying
- Lauren Solano: Mapping Careers Beyond the Bench | Dr. GPCR Ecosystem
Each year she delivers roughly a hundred talks at universities and research institutions on resumes,
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Scientific Themes of the Conversation Institutional resilience and the architecture of a research lab
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
He earned his Ph.D. at the Massachusetts Institute of Technology, where he studied MHC class II structure-function
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
cumulative load of committee service, mentorship, and representation — and argues that real support requires institutions
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
took him from the University of Buenos Aires in Argentina to UC San Diego and through the National Institutes






























